Gamma heavy chain disease: a retrospective analysis of 6 cases.
作者信息
Chang Long, Zhou Dao-Bin, Cao Xin-Xin
机构信息
Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Beijing, China.
出版信息
Orphanet J Rare Dis. 2023 Apr 11;18(1):77. doi: 10.1186/s13023-023-02679-5.
Abstract
摘要
相似文献
1
Gamma heavy chain disease: a retrospective analysis of 6 cases.
Orphanet J Rare Dis. 2023 Apr 11;18(1):77. doi: 10.1186/s13023-023-02679-5.
2
Discovery of a gamma heavy chain disease in a patient followed-up for a lymphoplasma cell proliferative disorder.
Ann Biol Clin (Paris). 2016 Jun 1;74(3):338-40. doi: 10.1684/abc.2016.1149.
3
Electrophoretic characterization of a gamma-1-heavy chain disease.
Neoplasma. 2000;47(2):118-21.
4
Identification of gamma heavy chain disease using MALDI-TOF mass spectrometry.
Clin Biochem. 2020 Mar;77:57-61. doi: 10.1016/j.clinbiochem.2019.12.010. Epub 2019 Dec 26.
5
Gamma heavy chain disease in a patient with underlying lymphoplasmacytic lymphoma of the thyroid. Report of a case and comparison with other reported cases with thyroid involvement.
Clin Chim Acta. 2012 Oct 9;413(19-20):1696-9. doi: 10.1016/j.cca.2012.04.020. Epub 2012 Apr 25.
6
Primary Sjögren's syndrome and gamma heavy chain disease.
Pathology. 1994 Jul;26(3):337-8. doi: 10.1080/00313029400169791.
7
Gamma heavy chain "disease": heterogeneity of the clinicopathologic features. Report of 16 cases and review of the literature.
Medicine (Baltimore). 1989 Nov;68(6):321-35.
8
Gamma-heavy chain disease: review of 23 cases.
Medicine (Baltimore). 2003 Jul;82(4):236-50. doi: 10.1097/01.md.0000085058.63483.7f.
9
Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management.
Kidney Int. 2017 Feb;91(2):423-434. doi: 10.1016/j.kint.2016.09.004. Epub 2016 Oct 20.
10
Gamma heavy chain disease simulating alpha chain disease.
Gut. 1978 Dec;19(12):1148-52. doi: 10.1136/gut.19.12.1148.
引用本文的文献
1
Uncommon Entities, Uncommon Challenges: A Review of Rare Plasma Cell Disorders.
Hematol Rep. 2025 Jun 27;17(4):31. doi: 10.3390/hematolrep17040031.
本文引用的文献
1
Gamma heavy chain disease associated with rheumatoid arthritis: a case report.
J Med Case Rep. 2021 Mar 17;15(1):121. doi: 10.1186/s13256-021-02696-7.
2
Gamma heavy chain disease complicated by pulmonary hypertension, which was successfully treated with lenalidomide.
BMJ Case Rep. 2020 Nov 30;13(11):e236162. doi: 10.1136/bcr-2020-236162.
3
γ heavy chain disease presenting in a patient with systemic lupus erythematosus.
Blood. 2020 Jun 4;135(23):2110. doi: 10.1182/blood.2019003973.
4
Heavy Lifting: Nomenclature and Novel Therapy for Gamma Heavy Chain Disease and Other Heavy Chain Disorders.
Clin Lymphoma Myeloma Leuk. 2020 Aug;20(8):493-498. doi: 10.1016/j.clml.2020.02.020. Epub 2020 Mar 6.
5
Heavy chain disease: our experience.
Clin Chem Lab Med. 2017 Nov 27;56(1):e10-e12. doi: 10.1515/cclm-2017-0254.
6
The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
Blood. 2016 May 19;127(20):2375-90. doi: 10.1182/blood-2016-01-643569. Epub 2016 Mar 15.
7
Gamma Heavy Chain Disease with T-cell Large Granular Lymphocytic Leukemia: A Case Report and Review of the Literature.
Intern Med. 2016;55(4):399-403. doi: 10.2169/internalmedicine.55.5042. Epub 2016 Feb 15.
8
Analysis of patients with γ-heavy chain disease by the heavy/light chain and free light chain assays.
Clin Chem Lab Med. 2014 May;52(5):665-9. doi: 10.1515/cclm-2013-0714.
9
Successful treatment of γ-heavy-chain disease with rituximab and fludarabine.
Acta Haematol. 2012;128(3):139-43. doi: 10.1159/000339097. Epub 2012 Aug 10.
10
Gamma heavy-chain disease: defining the spectrum of associated lymphoproliferative disorders through analysis of 13 cases.
Am J Surg Pathol. 2012 Apr;36(4):534-43. doi: 10.1097/PAS.0b013e318240590a.
Zotero 插件